CRIS Current Research Information System

CROCI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.521
AS - Asia 1.891
EU - Europa 1.517
AF - Africa 149
SA - Sud America 85
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.484
VN - Vietnam 708
SG - Singapore 441
CN - Cina 428
GB - Regno Unito 394
DE - Germania 199
IT - Italia 188
SE - Svezia 164
HK - Hong Kong 113
UA - Ucraina 95
RU - Federazione Russa 91
FR - Francia 90
IN - India 70
CH - Svizzera 67
BR - Brasile 57
IE - Irlanda 52
CI - Costa d'Avorio 47
TG - Togo 39
JP - Giappone 38
ZA - Sudafrica 37
CA - Canada 32
NL - Olanda 30
EE - Estonia 26
BG - Bulgaria 25
FI - Finlandia 24
BE - Belgio 18
RO - Romania 14
KR - Corea 13
PH - Filippine 13
AR - Argentina 10
LT - Lituania 10
TH - Thailandia 9
ID - Indonesia 8
NG - Nigeria 8
PL - Polonia 8
TR - Turchia 8
SC - Seychelles 7
CL - Cile 6
TW - Taiwan 6
CO - Colombia 5
ES - Italia 5
IR - Iran 5
JO - Giordania 5
BD - Bangladesh 4
GR - Grecia 4
PK - Pakistan 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
EC - Ecuador 3
EG - Egitto 3
IQ - Iraq 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CZ - Repubblica Ceca 2
HR - Croazia 2
KH - Cambogia 2
LV - Lettonia 2
MX - Messico 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GH - Ghana 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 6.168
Salva come PNG Salva come JPEG
Città #
Southend 318
Chandler 317
Singapore 299
Ashburn 277
Fairfield 268
Ho Chi Minh City 164
Hanoi 138
Woodbridge 127
Seattle 124
Wilmington 123
Houston 121
Ann Arbor 106
Hong Kong 106
Dong Ket 87
Cambridge 85
Princeton 75
San Jose 70
Santa Clara 70
Jacksonville 60
Bern 58
Beijing 56
Dublin 52
Abidjan 47
Hefei 46
Boardman 45
Lomé 39
Tokyo 32
Westminster 32
Nanjing 31
Lauterbourg 29
Padova 29
Bologna 28
Dallas 25
Haiphong 25
Sofia 25
Bremen 24
Los Angeles 22
Milan 22
Jinan 21
New York 21
Berlin 20
Helsinki 20
Brussels 18
Redwood City 18
Da Nang 17
Guangzhou 17
Shenyang 17
Ottawa 16
Falkenstein 15
Saint Petersburg 15
Buffalo 14
Changsha 12
Council Bluffs 12
Turin 12
Hebei 11
London 11
Nanchang 11
Phoenix 11
San Diego 11
Seoul 11
Frankfurt am Main 10
Hải Dương 10
Redondo Beach 10
Mülheim 9
Tianjin 9
Toronto 9
Zhengzhou 9
Jiaxing 8
Johannesburg 8
Moscow 8
São Paulo 8
Amsterdam 7
Bengaluru 7
Dearborn 7
Jakarta 7
Kuban 7
Mahé 7
Abeokuta 6
Atlanta 6
Can Tho 6
Des Moines 6
Ha Long 6
Thái Nguyên 6
Warsaw 6
Yubileyny 6
Amman 5
Bulle 5
Bühl 5
Montreal 5
Nha Trang 5
Ningbo 5
Quận Ba 5
Quận Bình Thạnh 5
Taizhou 5
Washington 5
Barnet 4
Biên Hòa 4
Bắc Ninh 4
Bến Tre 4
Leawood 4
Totale 4.191
Salva come PNG Salva come JPEG
Nome #
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. 380
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome 265
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 245
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R 244
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor 227
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. 216
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. 210
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy 209
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. 200
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines 196
In silico modeling and in vivo efficacy of cancer preventive vaccinations 196
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis 187
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. 185
Antimetastatic activity of a preventive cancer vaccine. 185
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 184
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 184
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. 184
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 184
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 182
Isolation and in vitro differentiation of human Mesenchymal Stem Cells from new alternative sources: fetal membranes and placenta 179
Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. 176
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells 171
Immunological prevention of a multigene cancer syndrome 164
Translational immunomics of cancer prevention. 162
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. 160
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. 158
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells 149
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent 147
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine 145
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system 144
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes 132
Toward the definition of immunosuppressive regimens with antitumor activity. 122
Expression of T cell receptor alpha gene (TCRA) in human rhabdomyosarcoma and other musculo-skeletal sarcomas. 118
null 95
Totale 6.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.136
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021210 0 0 0 0 0 0 0 0 0 30 25 155
2021/2022699 66 17 55 24 54 27 18 48 26 57 178 129
2022/2023981 117 146 61 146 54 71 21 46 128 38 68 85
2023/2024209 9 41 7 26 17 48 12 18 5 11 6 9
2024/2025706 55 85 56 33 126 53 39 26 6 42 33 152
2025/20261.677 305 142 141 124 192 87 132 32 389 133 0 0
Totale 6.285